4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000899243-23-010140
Chief Legal Officer acquired 8,941 shares (option exercise)
- Chief Legal Officer acquired 17,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bellon Christine Chief Legal Officer | 2023-03-30 | Option exercise | +6,272 | $7.22 | $45,284 | 64,713 | D |
| Bellon Christine Chief Legal Officer | 2023-03-30 | Option exercise | +2,669 | $7.22 | $19,270 | 67,382 | D |
| Bellon Christine Chief Legal Officer | 2023-03-31 | Grant or award | +17,500 | 84,882 | D | ||
| Derivatives | |||||||
| Bellon Christine Chief Legal Officer | 2023-03-30 | Option exercise · Stock Option (Right to Buy) | −6,272 | 13,674 | D | ||
| Bellon Christine Chief Legal Officer | 2023-03-30 | Option exercise · Stock Option (Right to Buy) | −2,669 | 16,736 | D | ||
Loading xslF345X04/doc4.xml…